Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-01-2023 | Hepatocellular Carcinoma | Case report

Atezolizumab/bevacizumab

Variceal bleed: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Kulkarni AV, et al. CHILD-PUGH CLASS DETERMINES THE OUTCOME OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH ATEZOLIZUMAB AND BEVACIZUMAB- A REAL-WORLD EXPERIENCE. Hepatology 76 (Suppl. 1): S1435 abstr. 4571, Oct 2022. Available from: URL: http://doi.org/10.1002/hep.32697 [abstract] Kulkarni AV, et al. CHILD-PUGH CLASS DETERMINES THE OUTCOME OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH ATEZOLIZUMAB AND BEVACIZUMAB- A REAL-WORLD EXPERIENCE. Hepatology 76 (Suppl. 1): S1435 abstr. 4571, Oct 2022. Available from: URL: http://​doi.​org/​10.​1002/​hep.​32697 [abstract]
Metadata
Title
Atezolizumab/bevacizumab
Variceal bleed: case report
Publication date
01-01-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-30393-y

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Insulin

Case report

Alteplase

Case report

Digoxin

Case report

Tranexamic acid